Home › Funds › PERCEPTIVE ADVISORS LLC › SLS
PERCEPTIVE ADVISORS LLC position in SLS
SELLAS LIFE SCIENCES GROUP I · Health Care
PERCEPTIVE ADVISORS LLC reported holding 2,500,000 shares of SLS (SELLAS LIFE SCIENCES GROUP I) in its Q3 2026 13F filing — a position valued at US$30.8M, representing 0.59% of its reported portfolio and ranking #33 among its reported holdings. PERCEPTIVE ADVISORS LLC has disclosed SLS holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How PERCEPTIVE ADVISORS LLC's SLS position evolved
PERCEPTIVE ADVISORS LLC first disclosed a stake in SLS in Q2 2026 at 1,500,000 shares (US$22.1M). The position peaked in Q3 2026 at 2,500,000 shares, worth US$30.8M. Across 2 filings, PERCEPTIVE ADVISORS LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 2,500,000 shares valued at US$30.8M — an increase of 1,000,000 shares quarter over quarter.. Notable position changes include a 67% increase in Q3 2026 (shares fell 39% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 1.50M | $22.14M | New |
| Q3 2026 | 2.50M | $30.77M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About SLS and 13F data
SLS (SELLAS LIFE SCIENCES GROUP I) is a Health Care company. 96 other funds we track also report a position in SLS — the largest reported positions include Anson Funds Management LP (US$38.2M), DAGCO, INC. (US$16.5M), Sio Capital Management, LLC (US$15.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding SLS
- Anson Funds Management LP 3.10M sh · $38.16M · Q3 2026
- DAGCO, INC. 1.34M sh · $16.45M · Q3 2026
- Sio Capital Management, LLC 1.23M sh · $15.15M · Q3 2026
- Opus Capital Group, LLC 403.63K sh · $4.97M · Q3 2026
- Ikarian Capital, LLC 354.70K sh · $4.37M · Q3 2026
- Murchinson Ltd. 200.00K sh · $2.46M · Q3 2026
- FULCRUM WEALTH ADVISORS, LLC 85.45K sh · $1.05M · Q3 2026
- VISION FINANCIAL MARKETS LLC 57.00K sh · $701.67K · Q3 2026
More on PERCEPTIVE ADVISORS LLC
FAQ
How long has PERCEPTIVE ADVISORS LLC held SLS?
PERCEPTIVE ADVISORS LLC has disclosed SLS holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
What is PERCEPTIVE ADVISORS LLC's current position in SLS?
As of Q3 2026, PERCEPTIVE ADVISORS LLC holds 2.50M shares of SLS (SELLAS LIFE SCIENCES GROUP I), valued at $30.77M, representing 0.59% of its reported portfolio and ranking #33.
Has PERCEPTIVE ADVISORS LLC been buying or selling SLS?
In the latest 13F filing (Q3 2026), PERCEPTIVE ADVISORS LLC increased its position in SLS. The position peaked in Q3 2026 at 2.50M shares.
Which other funds hold SLS?
Other major institutional holders of SLS include Anson Funds Management LP, DAGCO, INC., Sio Capital Management, LLC, among 96 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.